Condition

Chemotherapy-induced Peripheral Neuropathy clinical trials and research

As of November 12, 2026, Find a Trial lists 36 Chemotherapy-induced Peripheral Neuropathy clinical trials that are recruiting, at sites in 25 countries (most in United States (17), Spain (3), Italy (3)). By phase: Phase 2 (4), Phase 2/3 (2), Phase 1 (1), Phase 3 (1). The most active sponsors are University of Michigan Rogel Cancer Center (2), Hospital Universitario de Gran Canaria Doctor Negrín (2), M.D. Anderson Cancer Center (2). There are also 41 NIH-funded research projects on Chemotherapy-induced Peripheral Neuropathy, with $19.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Chemotherapy-induced Peripheral Neuropathy clinical trials

StudyPhaseWhereStatusRegistered
Cryotherapy during weekly paclitaxel to reduce chemotherapy-induced numbness and tingling — Bolzano, Bolzano and 3 other locations Recruiting Aug 24, 2026
SIR2501 plus Paclitaxel for solid tumors Phase 2 Hollywood, Florida and 4 other locations Recruiting Aug 14, 2026
Non-invasive brain stimulation to help chemotherapy-induced nerve problems in cancer survivors — Ann Arbor, Michigan Recruiting Jun 29, 2026
Self-applied ear vagus nerve stimulation for chemotherapy-induced neuropathy — Coral Gables, Florida Recruiting May 19, 2026
Blood extracellular vesicles to detect chemotherapy-related nerve damage. — Milan Recruiting Apr 30, 2026
Virtual LASO-3 diet program to ease chemotherapy-related numbness and tingling — Ann Arbor, Michigan Recruiting Jan 23, 2026
Ozone therapy for refractory pain and quality of life in cancer patients — Las Palmas de Gran Canaria, Las Palmas Recruiting Jan 8, 2026
Scrambler Therapy for chemotherapy-related nerve pain (CIPN). — Cleveland, Ohio Recruiting Oct 21, 2025
Video-guided imagined acupuncture for chemotherapy-related nerve pain — Charlestown, Massachusetts Recruiting Sep 17, 2025
Compression stockings to prevent peripheral neuropathy in patients receiving MMAE-containing ADCs for urothelial cancer — Shanghai Recruiting Sep 10, 2025

All recruiting trials (36)

NIH-funded research (newest 40 of 41)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

Related topics

CIPN - Chemotherapy-Induced Peripheral NeuropathyMalignant Solid NeoplasmHematopoietic and Lymphatic System NeoplasmPain, NeuropathicAcupunctureAdvanced Solid TumorsAntibody-drug ConjugatesBalance TrainingBreast CancerBreast Cancer PatientsBreast CarcinomaBreast NeoplasmsChemotherapyChemotherapy Induced Peripheral Neuropathy (CIPN)

Quick answers

How many Chemotherapy-induced Peripheral Neuropathy clinical trials are recruiting right now?

36, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 25 countries. The most sites are in United States (17 trials), Spain (3 trials), Italy (3 trials), Denmark (3 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 2/3: 2, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.